Administration time-dependent effects of raloxifen in postmenopausal women with osteoporosis.

Trial Profile

Administration time-dependent effects of raloxifen in postmenopausal women with osteoporosis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Aug 2013

At a glance

  • Drugs Raloxifene (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 31 Aug 2013 Results presented at the 11th Congress of the European Association for Clinical Pharmacology and Therapeutics.
    • 30 Jul 2012 Additional lead trial centre added as reported by University Hospital Medical Information Network - Japan record.
    • 30 Jul 2012 Actual end date (30 Jul 2012) added as reported by University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top